Consequently, molecular imaging techniques targeting specific PCa biomarkers, such as the prostate-specific membrane antigen (PSMA) and androgen receptor (AR), have recently gained significant attention [4,5,6,7,8]. The gene discussed is AR; the disease is posterior cortical atrophy.